Certificate of Analysis
Peptides
Tirzepatide
A dual GIP and GLP-1 receptor peptide analog for comparative signaling research.
$120
Per unit
1
For in vitro laboratory research only. Not for human or veterinary use, or as a dietary supplement.
Research profile
Scientific background
Tirzepatide, originally designated LY3298176, is a peptide analog with activity at GIP and GLP-1 receptors. The discovery paper includes signaling and functional assays in cell systems expressing recombinant or endogenous incretin receptors.
Laboratory research topics
- Comparative GIP- and GLP-1-receptor signaling assays.
- Functional readouts in defined receptor-expressing cell systems.
Evidence in context
Laboratory assays within original discovery research
Receptor expression and assay design affect comparative readouts. The cited laboratory preparations and clinical formulations are distinct from this research material.
Published studies describe their own experimental models and preparations. They do not establish the identity, quality, or suitability of an EliteGen batch for a particular experiment.
References 1
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
2018 · Original discovery study with cell-based, animal and clinical components
Product documents
Certificate of Analysis
These reports describe the specific samples and lots listed in each PDF. Compare the report’s lot details with the product documentation.
How to read a Certificate of Analysis
Match the sample
Compare the compound, amount, lot number, and report date with the material's documentation. Results describe the sample identified in that report.
Read the result and its units
The nominal amount identifies the sample as labeled. An assay reports a measured result. Read the method, units, and specification together; mg per vial and mg/g are different measurements.
Check what was tested
Identity, purity, assay, sterility, and endotoxins are separate tests. A purity percentage alone does not establish sterility or endotoxin levels. Use only the tests and results actually reported.
Specifications & Documents
- Compound
- Tirzepatide
- Selected amount
- 10 mg
- Country of Manufacture
- USA
- Intended use
- In vitro laboratory research only
- Certificate of Analysis
- 1 report available above for the selected amount.
- COA coverage
- Report-specific samples and lots.
Review the applicable batch documents before purchasing. Catalogue information is not a batch-specific certificate of analysis.
The research library
Read the science.
Understand the documents.
Analytical documentation01
How to read a Certificate of Analysis
A practical reading order for connecting a report to its sample and understanding what each reported result means.
3 min readRead guide Analytical methods02HPLC, mass spectrometry and peptide content
Understand the measurement behind a result before comparing percentages, molecular masses or amounts.
3 min readRead guide